Benefits of a Combined eCOA/eConsent Solution

September 20, 2016 Mika Lindroos

Research sponsors and investigative sites are continuing to explore the use of eConsent in today’s clinical trials. Driven by the promise of improved support for participant comprehension and prevention of common consent regulatory deficiencies, switching to an electronic approach can reduce regulatory risk through the capturing of better quality data and a documented informed consent process.  Read the full article on Applied Clinical Trials >

About the Author

Mika Lindroos

Director of Product Management, CRF Health

Previous Article
10 Steps for Successful Migration of COA from Paper to Electronic
10 Steps for Successful Migration of COA from Paper to Electronic

Next Article
Understanding the EMA Oncology PRO Guideline Appendix – We Can Help!
Understanding the EMA Oncology PRO Guideline Appendix – We Can Help!